Previous 10 | Next 10 |
Boston Scientific ( NYSE: BSX ) to make a partial offer to acquire a majority stake, up to a maximum of 65%, of shares of Acotec Scientific, a Chinese medical technology company that offers solutions designed for a variety of interventional procedures. The Acotec portfolio also in...
Boston Scientific Announces Strategic Investment to Acquire Majority Stake of Acotec Scientific Holdings Limited PR Newswire MARLBOROUGH, Mass. , Dec. 11, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) and Acotec Scientific Holdings Limited ("Acot...
Summary Nevro is a company that has developed a spinal cord stimulation implant to treat chronic pain. The FDA approved device is implanted into the back and has a good amount of clinical data to support the efficacy. Future growth relies on expanded geography, utilization, and the ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: venusvi / Shutterstock.com One of the medical technology sector’s most dynamic players is maneuvering to gain a bigger market share. This morning, Boston Scientific (NYSE: BSX ) announced that it is...
Boston Scientific Announces Agreement to Acquire Apollo Endosurgery, Inc. PR Newswire Acquisition to expand endoluminal surgery portfolio and add differentiated technologies for endobariatric procedures MARLBOROUGH, Mass. , Nov. 29, 2022 /PRNewswi...
Late-Breaking Post-Market Study Data Reinforce Clinical Procedural Success and Safety of the ACURATE neo2™ Aortic Valve System PR Newswire MARLBOROUGH, Mass. , Nov. 27, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) has announced the...
Summary Healthcare industry, especially the large-cap pharmaceutical, biotechnology, and managed healthcare stocks are doing well and outperforming the market. More stocks in THQ’s top 70 percent equity portfolio generated high positive price growth than the number of stock...
Boston Scientific Corporation (BSX) Q3 2022 Earnings Conference Call October 26, 2022 08:00 AM ET Company Participants Lauren Tengler - Vice President, Investor Relations Mike Mahoney - Chairman & Chief Executive Officer Dan Brennan - Executive Vice President...
Boston Scientific ( NYSE: BSX ) dropped ~4% pre-market Wednesday after the health equipment maker reported Q3 2022 results and set a lower-than-expected guidance for the current quarter and the full year. Net sales for the period exceeded Wall Street expectations to ...
Boston Scientific press release ( NYSE: BSX ): Q3 Non-GAAP EPS of $0.43 misses by $0.01 . Revenue of $3.17B (+8.2% Y/Y) beats by $30M . MedSurg: 6.5 percent reported, 11.0 percent operational and 9.8 percent organic Cardiovascular: 9.1 percent reported, 15....
News, Short Squeeze, Breakout and More Instantly...
Boston Scientific Corporation Company Name:
BSX Stock Symbol:
NYSE Market:
Boston Scientific Corporation Website:
Alkermes plc (ALKS) is expected to report $0.64 for Q2 2024 Acerinox ADR (ANIOY) is expected to report for Q2 2024 Allegion plc (ALLE) is expected to report $1.77 for Q2 2024 Deutsche Bank AG (DB) is expected to report $0.43 for Q2 2024 Pathward Financial Inc. (CASH) is expected t...
Boston Scientific Announces Results for Second Quarter 2024 PR Newswire MARLBOROUGH, Mass. , July 24, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $4.120 billion during the second quarter of 2024, growing 14.5 percent ...
Shares of Boston Scientific Corporation (NYSE: BSX) traded at a new 52-week high today and are currently trading at $78.31. So far today, approximately 1.5M shares have been exchanged, as compared to an average 30-day volume of 5.37M shares. Boston Scientific Corporation develops, manufacture...